NovAliX

Novalix is a contract research organization and drug discovery partner serving biotechnology firms and pharmaceutical companies. Based in Strasbourg, France, it supports the critical preclinical stages of research by combining experienced scientific teams, specialized technology and collaborative project models. Clients can work with Novalix through outsourced services or close, co-located collaboration with their own teams.

Its capabilities span chemistry, biophysics, pharmacology and drug metabolism and pharmacokinetics (DMPK), as well as integrated drug discovery support. Chemistry services include medicinal and process development, high-throughput synthesis, PROTACs, flow chemistry, and analytical chemistry and purification. The biophysics platform offers protein production, cryo-electron microscopy, X-ray crystallography, NMR, surface plasmon resonance and mass spectrometry. Pharmacology and DMPK services include biochemical and cellular assays, ADME-PK, early formulation, in vivo pharmacology, histology and PK/PD support. Novalix also provides cheminformatics and DNA-Encoded Library services. Its work covers areas such as oncology, immunology, infectious diseases, kidney disease, fibrosis, metabolic disorders and CNS research. The company applies its drug discovery expertise to cosmetics, offering testing, analytics, assays and ingredient-related services.